A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,582 shares of BIO stock, worth $859,573. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,582
Previous 772 234.46%
Holding current value
$859,573
Previous $210,000 310.95%
% of portfolio
0.02%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $477,785 - $623,798
1,810 Added 234.46%
2,582 $863,000
Q2 2024

Aug 13, 2024

SELL
$268.26 - $339.48 $174,369 - $220,662
-650 Reduced 45.71%
772 $210,000
Q1 2024

May 15, 2024

SELL
$304.11 - $351.99 $605,787 - $701,164
-1,992 Reduced 58.35%
1,422 $491,000
Q4 2023

Feb 13, 2024

BUY
$269.37 - $365.04 $710,059 - $962,245
2,636 Added 338.82%
3,414 $1.1 Million
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $114,531 - $138,200
327 Added 72.51%
778 $278,000
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $166,803 - $225,689
-464 Reduced 50.71%
451 $170,000
Q1 2023

May 09, 2023

BUY
$418.69 - $503.0 $180,036 - $216,290
430 Added 88.66%
915 $438,000
Q4 2022

Feb 10, 2023

SELL
$351.71 - $456.01 $2.85 Million - $3.69 Million
-8,094 Reduced 94.35%
485 $204,000
Q3 2022

Nov 10, 2022

BUY
$412.59 - $563.26 $2.77 Million - $3.79 Million
6,724 Added 362.48%
8,579 $3.58 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $317,613 - $409,054
-685 Reduced 26.97%
1,855 $919,000
Q1 2022

May 12, 2022

BUY
$524.57 - $735.42 $687,186 - $963,400
1,310 Added 106.5%
2,540 $1.43 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $585,501 - $656,405
826 Added 204.46%
1,230 $930,000
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $142,723 - $179,192
-217 Reduced 34.94%
404 $301,000
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $712,150 - $801,564
-1,235 Reduced 66.54%
621 $400,000
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $886,703 - $1.07 Million
1,621 Added 689.79%
1,856 $1.06 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $24,512 - $30,885
-48 Reduced 16.96%
235 $137,000
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $873,414 - $1.03 Million
-1,922 Reduced 87.17%
283 $146,000
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $738,388 - $1.09 Million
2,205 New
2,205 $996,000
Q4 2019

Feb 07, 2020

SELL
$319.73 - $374.2 $247,151 - $289,256
-773 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$304.55 - $345.24 $141,920 - $160,881
466 Added 151.79%
773 $257,000
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $359,810 - $391,987
-1,254 Reduced 80.33%
307 $96,000
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $323,664 - $458,022
1,443 Added 1222.88%
1,561 $477,000
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $456,927 - $641,484
-2,076 Reduced 94.62%
118 $27,000
Q3 2018

Nov 13, 2018

BUY
$289.28 - $326.15 $589,263 - $664,367
2,037 Added 1297.45%
2,194 $686,000
Q2 2018

Aug 15, 2018

SELL
$244.1 - $303.88 $402,520 - $501,098
-1,649 Reduced 91.31%
157 $45,000
Q1 2018

May 15, 2018

BUY
$233.97 - $274.11 $291,526 - $341,541
1,246 Added 222.5%
1,806 $452,000
Q4 2017

Feb 09, 2018

BUY
$216.94 - $271.3 $90,897 - $113,674
419 Added 297.16%
560 $134,000
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $29,930 - $34,161
141
141 $31,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.